LONDON, July 1, 2026, 18:02 BST
- Time To ACT plc AQSE:TTA had a single Aquis trade on Wednesday, with 30,000 shares moving at 13.75p. That’s £4,125 in total value. The official mid quote held steady at 12.50p.
- The 11p bid against a 14p ask puts the spread at 24% on the mid—tougher for anyone trying to trade in size than the headline price itself.
- The company reports 21,985,425 shares outstanding, with 75.4% held off-market. That puts the public float near £0.68 million at the 12.50p mid, according to .
- Time To ACT hasn’t put out any fresh RNS on Investegate in the last 48 hours. The latest item still showing is a June 8 private-investor event notice.
AQSE shut before the deadline, with usual trading hours from 0800 to 1630. Time To ACT plc AQSE:TTA didn’t see normal liquid recovery action on Wednesday. Only one trade went through—30,000 shares at 13.75p, or £4,125. The official mid sat at 12.50p, with bid at 11p and ask at 14p.
The latest trade printed 22.2% above the previous Aquis trade. That earlier trade was 13,461 shares at 11.25p on June 29. But the share price didn’t leap in a single move—Aquis kept the mid unchanged, showing a 0.0% change. For investors, this kind of tape shows execution risk. A small order can push the trade price but barely move the official mid.
| Latest Aquis prints | Shares | Price | Value | Read-through |
|---|---|---|---|---|
| July 1, 15:11 | 30,000 | 13.75p | £4,125 | Only one trade done in the session |
| June 29, 12:43 | 13,461 | 11.25p | £1,514 | Trade came down 22.2% from last |
| June 26, 16:21 | 20,000 | 11.50p | £2,300 | Stayed under the mid |
| June 26, 12:11 | 27,666 | 11.80p | £3,265 | Also a small size trade |
| June 25, 12:50 | 20,000 | 13.75p | £2,750 | Same price as Wednesday |
Time To ACT says it counts 21,985,425 shares outstanding as of April 14, with 75.4% locked up by insiders or other restricted holders. That means just 5.4 million shares sit in the float. At a 12.50p midpoint, those available shares are worth about £676,000. Volume remains tight. Wednesday’s 30,000-share trade—just 0.55% of the float—was enough to change the last price.
| Measure | Current figure | Investor read |
|---|---|---|
| Market cap at Aquis mid | £2.75 mln | Micro cap |
| Public-hands value, estimated | £0.68 mln | Low float |
| Bid-ask spread | 3p, or 24% of mid | Costly to get in or out |
| Wednesday turnover | £4,125 | 0.15% of the cap traded |
| Year range | 7.0p-17.5p | Stock sits 28.6% below peak |
The company hasn’t issued any new statements linked to the move. The most recent RNS on Investegate’s Time To ACT page was June 8, detailing CEO and Chief Strategy Officer Chris Heminway’s upcoming talk at a Yellowstone Advisory investor event on June 24. Previous updates included a June 3 options grant, a June 2 webinar notice, a hydrogen update on May 22, and the closing of an acquisition on May 19.
Time To ACT’s most recent major deal was the MTE acquisition. The company said on May 19 it had paid £500,000 for the business and assets of MTE Heat Treatment Limited, with £286,000 of that funded by equipment finance, and closed the deal through a new wholly owned subsidiary. MTE reported turnover of £2.834 million for 2025, down 21%. Time To ACT said it sees £3.0 million in sales and expects positive EBITDA and cash flow in the first full year with MTE.
Time To ACT’s £2.75 million market cap is smaller than the £3.0 million sales target for the business it’s picking up, so this deal tops the group’s current equity value. CEO Heminway called the MTE acquisition a “below the radar screen” move for larger competitors, and said it will add a “new layer of expertise” from both teams’ metallurgical know-how. Investegate
Time To ACT changed its capital structure fast. The company picked up £415,000 on April 2 after placing 6,916,664 new shares at 6p. Shares now sit at a 12.50p mid, more than double the raise price, up 108%. The April placing shares now represent roughly 31.5% of the company’s total shares as of April 14.
The company issued 1,305,000 options to directors and employees on June 3 at 9.5p. Of those, Chief Operating Officer Jason Moody received 487,500 options and Heminway got 387,500. The total grant represents about 5.9% of the current shares in issue. The exercise price lines up with the average mid-price from the past 30 trading days.
Diffusion Alloys is still the main operating risk. Time To ACT reported interim results for the six months to Sept. 30, 2025, with turnover dropping 56% to £732,370 from £1.665 million. The loss increased to £683,224 versus £169,494. Heminway called the stretch a “feast-to-famine” cycle and said the aim now is to “iron out this volatility.” Aquis
Hydrogen is next up. On May 22, Time To ACT said Diffusion Alloys is linked to Johnson Matthey plc (LON:JMAT) Catalyst Technologies, adding that EET Hydrogen and Power’s HPP1 blue-hydrogen project still targets a final investment decision in the second half of 2026. Heminway called the “long overdue FID” a positive and said HPP1 is financially important for Diffusion Alloys. Investegate
The board handoff hasn’t happened yet. CFO Gary Wallace is set to step down from both his CFO role and the board on July 17. His resignation was first announced in April. The search for a new finance chief is still open. Heminway said Wallace ran point on the 2024 IPO.
